Mycosis fungoides diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
Line 9: | Line 9: | ||
* The patient presents with symptomatic progressive skin lesions such as: patches, plaques, tumors, and erytheroderma, and a poorer prognosis in later stages. | * The patient presents with symptomatic progressive skin lesions such as: patches, plaques, tumors, and erytheroderma, and a poorer prognosis in later stages. | ||
There is no single diagnostic study of choice for the diagnosis of mycosis fungoides, and mycosis fungoides can be diagnosed difficult by nonspecific skin presentation. | * There is no single diagnostic study of choice for the diagnosis of mycosis fungoides, and mycosis fungoides can be diagnosed difficult by nonspecific skin presentation. | ||
* Mycosis fungoides is primarily diagnosed based on the clinical presentation. | |||
Mycosis fungoides is primarily diagnosed based on the clinical presentation. | |||
==References== | ==References== |
Revision as of 12:58, 4 January 2019
Mycosis fungoides Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mycosis fungoides diagnostic study of choice On the Web |
American Roentgen Ray Society Images of Mycosis fungoides diagnostic study of choice |
Risk calculators and risk factors for Mycosis fungoides diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
Diagnostic Study of Choice
Mycosi fungoides must be performed when:[1]
- The patient presents with symptomatic progressive skin lesions such as: patches, plaques, tumors, and erytheroderma, and a poorer prognosis in later stages.
- There is no single diagnostic study of choice for the diagnosis of mycosis fungoides, and mycosis fungoides can be diagnosed difficult by nonspecific skin presentation.
- Mycosis fungoides is primarily diagnosed based on the clinical presentation.